Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
screening for reproductive / developmental toxicity
Remarks:
based on test type (migrated information)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
July 2012 to March 2013
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2013

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
certificate nr 2011/40 on July 19th 2011
Limit test:
no

Test material

Constituent 1
Reference substance name:
PROCESS OIL
IUPAC Name:
PROCESS OIL
Test material form:
gas under pressure: refrigerated liquefied gas

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on mating procedure:
Females were paired with males from the same dose--level group. One female was placed with one male, in the latter's cage, during the night. Sibling pairings were avoided.
Confirmation of mating was made in the morning by checking for the presence of a vaginal plug or for sperm in a vaginal lavage.
There were no treatment-related effects on mating and fertility data. All animals mated within comparable mean number of days. All females were pregnant, except one in each of the 0, 100, and 300 mg/kg/day groups
Duration of treatment / exposure:
For males: - 5 weeks
For females: - 2 weeks before paring, during mating and pregnancy, until day 5 post-partum.
Frequency of treatment:
Daily
Details on study schedule:
The chronology of the study is summarized as follows:

Procedure Calendar Date
Study plan approved by
. Study Director 23 October 2012
. Sponsor Representative 05 November 2012

Experimental starting date
(day of arrival of the animals) 25 October 2012
. Identification, weighing and randomization 26 October 2012

First day of treatment 31 October 2012

Mating (day 0 p.c.)
. first females 15 November 2012
. last females 18 November 2012

Functional Observation Battery and motor activity
. males 05 December 2012
. females 11 to 13 December 2012

Hematology and blood biochemistry
. males 06 December 2012
. females 12 to 14 December 2012

Delivery (day 0 p.p.)
. first females 06 December 2012
. last females 09 December 2012

Necropsy date of males 06 December 2012

Necropsy date of females (day 6 p.p.)
. first females 12 December 2012
. last females 15 December 2012

Experimental completion date 11 February 2013

Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
0 mg/kg/day 0 mg/mL
Basis:
nominal in water
Remarks:
Doses / Concentrations:
100 mg/kg/day 20 mg/mL
Basis:
nominal in water
Remarks:
Doses / Concentrations:
300 mg/kg/day 60 mg/mL
Basis:

Remarks:
Doses / Concentrations:
1000 mg/kg/day 200 mg/mL
Basis:

No. of animals per sex per dose:
10
Control animals:
yes

Results and discussion

Results: P0 (first parental generation)

Effect levels (P0)

Dose descriptor:
NOEL
Effect level:
1 000 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
male/female

Overall reproductive toxicity

Reproductive effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
Based on the experimental conditions of the study:
- The No Observed Effect Level (NOEL) for reproductive performance was considered to be 1000 mg/kg/day in the absence of any treatment-related effect on mating and fertility at this dose-level.